ConforMIS, Inc. (NasdaqGS:CFMS) is seeking acquisition. The company intends to use the net proceeds from the sale of any securities of the amount of approximately $200 million for general corporate purposes. General corporate purposes may include research and development costs, sales and marketing costs, clinical studies, manufacturing development, the acquisition or licensing of other businesses or technologies, repayment and refinancing of debt, working capital and capital expenditures.